Blade Clinical Trials

Today, we are advancing a differentiated pipeline of oral, small-molecule therapies that include a non-competitive autotaxin inhibitor and inhibitors of dimeric calpains for the potential treatment of lung, liver and cardiac fibrosis or neurodegenerative diseases.

Find Clinical Trials Near Me

Study	Description	Study Phase	Status	Trial number
BLD-0409-101	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics	Phase 1	Complete	NCT04146805
BLD-0409-102	Relative Bioavailability	Phase 1	Complete	NCT04814472
BLD-0409-103	Drug-Drug Interaction with Probe Substrates for CYP450 Enzymes	Phase 1	Complete	NCT04814498
BLD-0409-104	Drug-Drug Interaction with Approved Therapies for IPF	Phase 1	Complete	NCT04939467
BLD-0409-201	Idiopathic Pulmonary Fibrosis	Phase 2	Planned	NCT05373914